Cargando…

The impact of COVID-19 and control measures on public health in Thailand, 2020

BACKGROUND: The COVID-19 virus has been an emerging disease causing global outbreaks for over a year. In Thailand, transmission may be controlled by strict measures that could positively and negatively impact physical health and suicidal behavior. METHODS: The incidence of COVID-19 was retrieved fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yorsaeng, Ritthideach, Suntronwong, Nungruthai, Thongpan, Ilada, Chuchaona, Watchaporn, Lestari, Fajar Budi, Pasittungkul, Siripat, Puenpa, Jiratchaya, Atsawawaranunt, Kamolthip, Sharma, Chollasap, Sudhinaraset, Natthinee, Mungaomklang, Anek, Kitphati, Rungrueng, Wanlapakorn, Nasamon, Poovorawan, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2022
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857899/ https://www.ncbi.nlm.nih.gov/pubmed/35190788 http://dx.doi.org/10.7717/peerj.12960

Ejemplares similares

High prevalence of circulating DS-1-like human rotavirus A and genotype diversity in children with acute gastroenteritis in Thailand from 2016 to 2019
por: Pasittungkul, Siripat, et al.
Publicado: (2021)

Molecular epidemiology of the first wave of severe acute respiratory syndrome coronavirus 2 infection in Thailand in 2020
por: Puenpa, Jiratchaya, et al.
Publicado: (2020)

High prevalence of DS-1-like rotavirus infection in Thai adults between 2016 and 2019
por: Chansaenroj, Jira, et al.
Publicado: (2020)

Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data
por: Wanlapakorn, Nasamon, et al.
Publicado: (2022)

Respiratory syncytial virus, human metapneumovirus, and influenza virus infection in Bangkok, 2016-2017
por: Thongpan, Ilada, et al.
Publicado: (2019)

Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients
por: Chansaenroj, Jira, et al.
Publicado: (2021)

Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients
por: Chansaenroj, Jira, et al.
Publicado: (2022)

SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis
por: Yorsaeng, Ritthideach, et al.
Publicado: (2023)

Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients
por: Chansaenroj, Jira, et al.
Publicado: (2021)

COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron
por: Suntronwong, Nungruthai, et al.
Publicado: (2022)

SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study
por: Suntronwong, Nungruthai, et al.
Publicado: (2023)

Evolutionary and Genetic Recombination Analyses of Coxsackievirus A6 Variants Associated with Hand, Foot, and Mouth Disease Outbreaks in Thailand between 2019 and 2022
por: Puenpa, Jiratchaya, et al.
Publicado: (2022)

SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020
por: Chirathaworn, Chintana, et al.
Publicado: (2020)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
por: Yorsaeng, Ritthideach, et al.
Publicado: (2022)

Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine
por: Chansaenroj, Jira, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 antibodies and associated factors among household contacts of COVID-19 confirmed cases in Bangkok, Thailand
por: Atsawawaranunt, Kamolthip, et al.
Publicado: (2023)

The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

Recombinant GII.Pe-GII.4 Norovirus, Thailand, 2017–2018
por: Chuchaona, Watchaporn, et al.
Publicado: (2019)

Strong Correlations between the Binding Antibodies against Wild-Type and Neutralizing Antibodies against Omicron BA.1 and BA.2 Variants of SARS-CoV-2 in Individuals Following Booster (Third-Dose) Vaccination
por: Suntronwong, Nungruthai, et al.
Publicado: (2022)

The History of Enterovirus A71 Outbreaks and Molecular Epidemiology in the Asia-Pacific Region
por: Puenpa, Jiratchaya, et al.
Publicado: (2019)

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
por: Wanlapakorn, Nasamon, et al.
Publicado: (2022)

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Human norovirus GII.4 Hong Kong variant shares common ancestry with GII.4 Osaka and emerged in Thailand in 2016
por: Chuchaona, Watchaporn, et al.
Publicado: (2021)

Dynamic Antibody Response and Hybrid Immunity Following Multiple COVID-19 Vaccine Doses and Infection: A Case Study
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax(TM)) after homologous and heterologous two-dose regimens
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023
por: Chansaenroj, Jira, et al.
Publicado: (2023)

Unusual skin manifestation of hand, foot and mouth disease associated with coxsackievirus A6: cases report
por: Chatproedprai, Susheera, et al.
Publicado: (2015)

Evaluation of Anti-S1 IgA Response to Different COVID-19 Vaccination Regimens
por: Bureerug, Teeraporn C., et al.
Publicado: (2023)

Prevalence of antibodies against seasonal influenza A and B viruses among older adults in rural Thailand: A cross-sectional study
por: Suntronwong, Nungruthai, et al.
Publicado: (2021)

Molecular characterisation and tracking of severe acute respiratory syndrome coronavirus 2 in Thailand, 2020–2022
por: Puenpa, Jiratchaya, et al.
Publicado: (2023)

A G3P[9] rotavirus strain with an unusual genome constellation in a diarrheic cat in Thailand
por: Lestari, Fajar Budi, et al.
Publicado: (2023)

Investigation of the Molecular Epidemiology and Evolution of Circulating Severe Acute Respiratory Syndrome Coronavirus 2 in Thailand from 2020 to 2022 via Next-Generation Sequencing
por: Puenpa, Jiratchaya, et al.
Publicado: (2023)

Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants
por: Hu, Siyuan, et al.
Publicado: (2022)

Epidemiology and clinical characteristics of severe acute respiratory infections among hospitalized children under 5 years of age in a tertiary care center in Bangkok, Thailand, 2019–2020
por: Wanlapakorn, Nasamon, et al.
Publicado: (2023)

Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination
por: Assawakosri, Suvichada, et al.
Publicado: (2022)

Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year
por: Kanokudom, Sitthichai, et al.
Publicado: (2023)

Rotavirus infection in children in Southeast Asia 2008–2018: disease burden, genotype distribution, seasonality, and vaccination
por: Lestari, Fajar Budi, et al.
Publicado: (2020)

Molecular surveillance of arboviruses circulation and co-infection during a large chikungunya virus outbreak in Thailand, October 2018 to February 2020
por: Khongwichit, Sarawut, et al.
Publicado: (2022)

Molecular epidemiology, clinical analysis, and genetic characterization of Zika virus infections in Thailand (2020–2023)
por: Khongwichit, Sarawut, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8rv8erhe5gilt4rdemanskicur